I
Intensity Therapeutics (INTS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Intensity Therapeutics (INTS)
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to treat solid tumor cancers. It leverages its DfuseRx technology platform to create proprietary drug formulations. Its product c... Read more
- USD0.34
- USD0.34
- USD0.32
- USD4.97
- 6.80%
- --
- 2.21M
- 3.25M
- 9M
- 0.26
- -93.40%
Stock News
4 hours ago
Trump sent Jeffrey Epstein 'bawdy' 50th birthday letter: WSJ
CNBC
yesterday
Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
CNBC
yesterday
Fed’s Waller says labor market is weaker than it looks, justifying interest-rate cut this month
MarketWatch
yesterday
Rocket Companies to Announce Second Quarter 2025 Results on July 31, 2025
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
